Cross-sectional study on the prevalence of sarcopenia and its association with physical function in patients with unresectable stage IV lung cancer undergoing drug therapy

Cross-sectional study on the prevalence of sarcopenia and its association with physical function in patients with unresectable stage IV lung cancer undergoing drug therapy - Cross-sectional study on the prevalence of sarcopenia and its association with physical function in patients with unresectable stage IV lung cancer undergoing drug therapy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000054708

Enrollment

Registered

2024-06-19

Start date

2022-01-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer(stage4)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Persons who have received a request for rehabilitation from the clinical department while hospitalized. 2) Persons who have given consent to undergo rehabilitation. 3) Persons who do not have significant joint range of motion limitations, sensory disorders, or motor paralysis in their limbs 4) Persons who can walk independently (with or without walking aids)

Exclusion criteria

Exclusion criteria: 1) Persons whose consent for this research was not obtained 2) Persons with a history of other malignant tumors 3) Persons with a pacemaker implanted 4) Persons who have restrictions on the degree of rest during rehabilitation during hospitalization

Design outcomes

Primary

Measure	Time frame
Prevalence of sarcopenia	—

Countries

Japan

Contacts

Public ContactTakumi Tsubaki

University of Tsukuba Hospital rehabilitation department

tsubaki.takumi.kw@ms.hosp.tsukuba.ac.jp0298533795

Outcome results